Optimization of Fluorescently Labeled Nrf2 Peptide Probes and the Development of a Fluorescence Polarization Assay for the Discovery of Inhibitors of Keap1-Nrf2 Interaction

被引:82
作者
Inoyama, Daigo [1 ]
Chen, Yu [1 ]
Huang, Xinyi [1 ]
Beamer, Lesa J. [2 ]
Kong, Ah-Ng Tony [3 ,4 ]
Hu, Longqin [1 ,4 ]
机构
[1] Rutgers State Univ, Dept Med Chem, Ernest Mario Sch Pharm, Piscataway, NJ 08854 USA
[2] Univ Missouri, Dept Biochem, Columbia, MO USA
[3] Rutgers State Univ, Dept Pharmaceut, Ernest Mario Sch Pharm, Piscataway, NJ 08854 USA
[4] Canc Inst New Jersey, New Brunswick, NJ USA
基金
美国国家卫生研究院;
关键词
Nrf2; Keap1; ARE; fluorescence polarization; high-throughput screening; oxidative response; OXIDATIVE STRESS; KELCH DOMAIN; CANCER CHEMOPREVENTION; BINDING; PATHWAY; PROTEIN; NEH2; MAF; UBIQUITINATION; IDENTIFICATION;
D O I
10.1177/1087057111430124
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Activation of the antioxidant response element (ARE) upregulates enzymes involved in detoxification of electrophiles and reactive oxygen species. The induction of ARE genes is regulated by the interaction between redox sensor protein Keap1 and the transcription factor Nrf2. Fluorescently labeled Nrf2 peptides containing the ETGE motif were synthesized and optimized as tracers in the development of a fluorescence polarization (FP) assay to identify small-molecule inhibitors of the Keap1-Nrf2 interaction. The tracers were optimized to increase the dynamic range of the assay and their binding affinities to the Keap1 Kelch domain. The binding affinities of Nrf2 peptide inhibitors obtained in our FP assay using FITC-9mer Nrf2 peptide amide as the probe were in good agreement with those obtained previously by a surface plasmon resonance assay. The FP assay exhibits considerable tolerance toward DMSO and produced a Z' factor greater than 0.6 in a 384-well format. Further optimization of the probe led to cyanine-labeled 9mer Nrf2 peptide amide, which can be used along with the FITC-9mer Nrf2 peptide amide in a high-throughput screening assay to discover small-molecule inhibitors of Keap1-Nrf2 interaction.
引用
收藏
页码:435 / 447
页数:13
相关论文
共 50 条
  • [21] Kinetic Analyses of Keap1-Nrf2 Interaction and Determination of the Minimal Nrf2 Peptide Sequence Required for Keap1 Binding Using Surface Plasmon Resonance
    Chen, Yu
    Inoyama, Daigo
    Ah-Ng Tony Kong
    Beamer, Lesa J.
    Hu, Longqin
    CHEMICAL BIOLOGY & DRUG DESIGN, 2011, 78 (06) : 1014 - 1021
  • [22] Drug-Repositioning Screening for Keap1-Nrf2 Binding Inhibitors using Fluorescence Correlation Spectroscopy
    Yoshizaki, Yuki
    Mori, Takayasu
    Ishigami-Yuasa, Mari
    Kikuchi, Eriko
    Takahashi, Daiei
    Zeniya, Moko
    Nomura, Naohiro
    Mori, Yutaro
    Araki, Yuya
    Ando, Fumiaki
    Mandai, Shintaro
    Kasagi, Yuri
    Arai, Yohei
    Sasaki, Emi
    Yoshida, Sayaka
    Kagechika, Hiroyuki
    Rai, Tatemitsu
    Uchida, Shinichi
    Sohara, Eisei
    SCIENTIFIC REPORTS, 2017, 7
  • [23] Perfluoroarene-based peptide macrocycles that inhibit the Nrf2/Keap1 interaction
    Steel, Richard J.
    O'Connell, Maria A.
    Searcey, Mark
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2018, 28 (16) : 2728 - 2731
  • [24] Nrf2 activation through the inhibition of Keap1–Nrf2 protein–protein interaction
    Sumi Lee
    Longqin Hu
    Medicinal Chemistry Research, 2020, 29 : 846 - 867
  • [25] Discovery of Potent Keap1-Nrf2 Protein-Protein Interaction Inhibitor Based on Molecular Binding Determinants Analysis
    Jiang, Zheng-Yu
    Lu, Meng-Chen
    Xu, Li-Li
    Yang, Ting-Ting
    Xi, Mei-Yang
    Xu, Xiao-Li
    Guo, Xiao-Ke
    Zhang, Xiao-Jin
    You, Qi-Dong
    Sun, Hao-Peng
    JOURNAL OF MEDICINAL CHEMISTRY, 2014, 57 (06) : 2736 - 2745
  • [26] Small molecules inhibiting Keap1-Nrf2 protein-protein interactions: a novel approach to activate Nrf2 function
    Zhuang, Chunlin
    Wu, Zhongli
    Xing, Chengguo
    Miao, Zhenyuan
    MEDCHEMCOMM, 2017, 8 (02) : 286 - 294
  • [27] Discovery of Keap1-Nrf2 small - molecule inhibitors from phytochemicals based on molecular docking
    Li, Maiquan
    Huang, Weisu
    Jie, Fan
    Wang, Mengmeng
    Zhong, Yongheng
    Chen, Qi
    Lu, Baiyi
    FOOD AND CHEMICAL TOXICOLOGY, 2019, 133
  • [28] Synthesis and Evaluation of Noncovalent Naphthalene-Based KEAP1-NRF2 Inhibitors
    Lazzara, Phillip R.
    Jain, Atul D.
    Maldonado, Amanda C.
    Richardson, Benjamin
    Skowron, Kornelia J.
    David, Brian P.
    Siddiqui, Zamia
    Ratia, Kiira M.
    Moore, Terry W.
    ACS MEDICINAL CHEMISTRY LETTERS, 2020, 11 (04): : 521 - 527
  • [29] KEAP1-NRF2 protein-protein interaction inhibitors: Design, pharmacological properties and therapeutic potential
    Crisman, Enrique
    Duarte, Pablo
    Dauden, Esteban
    Cuadrado, Antonio
    Rodriguez-Franco, Maria Isabel
    Lopez, Manuela G.
    Leon, Rafael
    MEDICINAL RESEARCH REVIEWS, 2023, 43 (01) : 237 - 287
  • [30] Peptide inhibitors of the Keap1-Nrf2 protein-protein interaction with improved binding and cellular activity
    Hancock, Rowena
    Schaap, Marjolein
    Pfister, Helene
    Wells, Geoff
    ORGANIC & BIOMOLECULAR CHEMISTRY, 2013, 11 (21) : 3553 - 3557